Sarcoma  >>  everolimus  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
everolimus / Generic mfg.
Radix, NCT00510354 / 2005-004837-16: Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate

Completed
4
28
Europe
Imatinib mesylate
Novartis Pharmaceuticals
Progressive Gastrointestinal Stromal Tumor
11/12
11/12

Download Options